Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 31, 2017 - Issue 21
319
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Yangonindimers A-C, three new kavalactone dimers from Piper methysticum (kava)

, , , , , , , ORCID Icon & show all
Pages 2459-2466 | Received 16 Jan 2017, Accepted 17 Mar 2017, Published online: 09 Apr 2017

References

  • Adrade da Mata Rezende CM, Von Bulow MV, Gottlieb OR, Lamego Vieira Pinho S, Da Rocha AI. 1971. The 2-pyrones of Aniba species. Phytochemistry. 10:3167–3171.
  • Bilia AR, Gallon S, Vincieri FF. 2002. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci. 70:2581–2597.10.1016/S0024-3205(02)01555-2
  • Dharmaratne HR, Dhammika Nanayakkaraa NP, Khana IA. 2002. Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses. Phytochemistry. 59:429–433.
  • Gigliarelli G, Pagiotti R, Persia D, Marcotullio MC. 2017. Optimisation of a Naviglio-assisted extraction followed by determination of piperine content in Piper longum extracts. Nat Prod Res. 31:214–217.10.1080/14786419.2016.1217209
  • Heilmann J, Wasescha MR, Schmidt TJ. 2001. The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. Bioorg Med Chem. 9:2189–2194.10.1016/S0968-0896(01)00131-6
  • Masanori K, Yooko Y, Seigo F, Akira U, Tadataka N, Toshio M. 1982. Chemical studies on the constituents of Polygonum nodosum. Chem Pharm Bull. 30:1602–1606.
  • Olsen LR, Grillo MP, Skonberg C. 2011. Constituents in kava extracts potentially involved in hepatotoxicity: a review. Chem Res Toxicol. 24:992–1002.10.1021/tx100412m
  • Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OD, Prasad AK, Wengel J, Olsen CE, Boll PM. 1997. Phytochemistry of the genus Piper. Phytochemistry. 46:597–673.10.1016/S0031-9422(97)00328-2
  • Pittler MH, Ernst E. 2000. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 20:84–89.10.1097/00004714-200002000-00014
  • Sagawa T, Takaishi Y, Fujimoto Y, Duque C, Osorio C, Ramos F, Garzon C, Sato M, Okamoto M, Oshikawa T, Ahmed SU. 2005. Cyclobutane dimers from the Colombian medicinal plant achyrocline bogotensis. J Nat Prod. 68:502–505.10.1021/np040187y
  • Sarris J, Kavanagh DJ. 2009. Kava and St. John’s wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med. 15:827–836.10.1089/acm.2009.0066
  • Shi YN, Yang L, Zhao JH, Shi YM, Qu Y, Zhu HT, Wang D, Yang CR, Li XC, Xu M, Zhang YJ. 2015. Chemical constituents from Piper wallichii. Nat Prod Res. 29:1372–1375.10.1080/14786419.2014.998217
  • Singh YN, Blumenthal M. 1997. Kava: an overview. Distribution, mythology, culture, chemistry and pharmacology of the South Pacific’s most revered herb. Herbalgram. 39:33–56.
  • Singh YN, Singh NN. 2002. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 16:731–743.10.2165/00023210-200216110-00002
  • Teschke R. 2010a. Kava hepatotoxicity: a clinical review. Ann Hepatol. 9:251–265.
  • Teschke R. 2010b. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int. 30:1270–1279.10.1111/j.1478-3231.2010.02308.x
  • Teschke R, Lebot V. 2011. Proposal for a kava quality standardization code. Food Chem Toxicol. 49:2503–2516.10.1016/j.fct.2011.06.075
  • Teschke R, Schwarzenboeck A, Hennermann KH. 2008. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol. 20:1182–1193.10.1097/MEG.0b013e3283036768
  • Teschke R, Qiu SX, Xuan TD, Lebot V. 2011. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res. 25:1262–1274.
  • Teschke R, Sarris J, Lebot V. 2011. Contaminant hepatotoxins as culprits for hepatotoxicity–fact or fiction? Phytother Res. 27:472–474.
  • Tu Y, Zhong Y, Du HJ, Luo W, Wen YY, Li Q, Zhu C, Li Y. 2016. Anticholinesterases and antioxidant alkamides from Piper nigrum fruits. Nat Prod Res. 30:1945–1949.10.1080/14786419.2015.1089243
  • Wang YH, Morris-Natschke SL, Yang J, Niu HM, Long CL, Lee KH. 2014. Anticancer principles from medicinal piper (hú jiāo) plants. J Tradit Complement Med. 4:8–16.10.4103/2225-4110.124811
  • Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. 2003. Kava lactones and the kava-kava controversy. Phytochemistry. 64:673–679.10.1016/S0031-9422(03)00381-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.